Literature DB >> 11739472

Depot-specific variation in protein-tyrosine phosphatase activities in human omental and subcutaneous adipose tissue: a potential contribution to differential insulin sensitivity.

X Wu1, J Hoffstedt, W Deeb, R Singh, N Sedkova, A Zilbering, L Zhu, P K Park, P Arner, B J Goldstein.   

Abstract

Compared with the sc depot, omental (om) adipose tissue is relatively resistant to the metabolic actions of insulin. Protein-tyrosine phosphatases (PTPases) modulate receptor kinase activation and signal transduction in insulin-sensitive tissues, and their activity is dependent on the reduced state of the cysteine thiol required for catalysis. Using a novel anaerobic technique to avoid air oxidation, we found that the mean endogenous PTPase activity was 2.1-fold higher in om compared with paired samples of sc adipose tissue (P < 0.003). The specific activity of PTP1B isolated under anaerobic conditions was also 41% higher in om adipose tissue (P < 0.001). Interestingly, the total PTPase activity from both adipose depots and the specific activity of PTP1B was increased by 42-71% after reduction in vitro with dithiothreitol, indicating that a major fraction of the cellular PTPase activity can be reactivated by sulfhydryl reduction. The mass of the insulin receptor beta-subunit and the PTPases PTP1B and leukocyte antigen related was not significantly different between the two adipose depots. These studies provide the first demonstration that endogenous PTPase activity, including PTP1B, is increased in om adipose tissue and may contribute to the relative insulin resistance of this fat depot. The finding that a substantial fraction of PTPase activity in human adipose tissue is present in a latent, oxidized form also suggests a potential means of in vivo regulation of these important cellular enzymes that modulate the insulin signaling cascade.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739472     DOI: 10.1210/jcem.86.12.8109

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

Review 1.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

Review 2.  Role of insulin-induced reactive oxygen species in the insulin signaling pathway.

Authors:  Barry J Goldstein; Kalyankar Mahadev; Xiangdong Wu; Li Zhu; Hiroyuki Motoshima
Journal:  Antioxid Redox Signal       Date:  2005 Jul-Aug       Impact factor: 8.401

3.  Rosiglitazone attenuates tumor necrosis factor-α-induced protein-tyrosine phosphatase-1B production in HepG2 cells.

Authors:  J Wu; L-J Yang; D-J Zou
Journal:  J Endocrinol Invest       Date:  2011-04-06       Impact factor: 4.256

Review 4.  The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression.

Authors:  Sang K Kim; Raymond F Novak
Journal:  Pharmacol Ther       Date:  2006-11-13       Impact factor: 12.310

Review 5.  Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Kamran Qureshi; Gary A Abrams
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

6.  Mechanisms involved in the development and healing of diabetic foot ulceration.

Authors:  Thanh Dinh; Francesco Tecilazich; Antonios Kafanas; John Doupis; Charalambos Gnardellis; Ermelindo Leal; Ana Tellechea; Leena Pradhan; Thomas E Lyons; John M Giurini; Aristidis Veves
Journal:  Diabetes       Date:  2012-06-11       Impact factor: 9.461

7.  Uncovering suitable reference proteins for expression studies in human adipose tissue with relevance to obesity.

Authors:  Rafael Pérez-Pérez; Juan A López; Eva García-Santos; Emilio Camafeita; María Gómez-Serrano; Francisco J Ortega-Delgado; Wifredo Ricart; José M Fernández-Real; Belén Peral
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

8.  Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle.

Authors:  Iria Nieto-Vazquez; Sonia Fernández-Veledo; Cristina de Alvaro; Margarita Lorenzo
Journal:  Diabetes       Date:  2008-09-16       Impact factor: 9.461

9.  Marine Bromophenol Derivative 3,4-Dibromo-5-(2-bromo-3,4-dihydroxy-6-isopropoxymethyl benzyl)benzene-1,2-diol Protects Hepatocytes from Lipid-Induced Cell Damage and Insulin Resistance via PTP1B Inhibition.

Authors:  Jiao Luo; Ning Wu; Bo Jiang; Lijun Wang; Shuaiyu Wang; Xiangqian Li; Baocheng Wang; Changhui Wang; Dayong Shi
Journal:  Mar Drugs       Date:  2015-07-17       Impact factor: 5.118

10.  The allelic variant of LAR gene promoter -127 bp T-->A is associated with reduced risk of obesity and other features related to insulin resistance.

Authors:  Giuseppe Miscio; Vittorio Tassi; Angelo Coco; Teresa Soccio; Rosa Di Paola; Sabrina Prudente; Roberto Baratta; Lucia Frittitta; Ornella Ludovico; Libera Padovano; Bruno Dallapiccola; Umberto Di Mario; Salvatore De Cosmo; Vincenzo Trischitta
Journal:  J Mol Med (Berl)       Date:  2004-05-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.